5Schulte SJ,Braron RL,Teefey SA,et al.CT of the extrahepatic bileduct: Wall thickness and contrast enhancement in normal and abnormal duct[J].AJR,1990,17(2):154～179. 被引量：1
6Fukukura Y,Fujiyoshi F,Sasaki M.Intraductal papiliary mucinous tumors of the pancreas:thin～section helical CT findings[J].AJR,2000,174(2):441～447. 被引量：1
7Gillams A,Gardende J,Richards R,et al.Three-dimensional computed tomography:a new technique for biliary tract imaging[J].Br J Radiol,1994,67(3):445～448. 被引量：1
4Weinreb JC, Maravilla KR, Redman HC, et al. Improved MR imaging of the upper abdomen with glucagon and gas. J Comput Assist Tomogr, 1984, 8: 835-838. 被引量：1
5Brown JJ, Duncan JR, Heiken JP, et al. Perfluorodtylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon. Radiology, 1991, 181:455-460. 被引量：1
6Hahn PF,Stark DD,Lewis JM,et al. First clinical trial of a new superparamagnetic irom oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology, 1990,175:695-700. 被引量：1
7Hirohashi S, Hirohashi R, Uchida H, et al. MR cholangiopancreatography and MR urography: improved enhancement with a negative oral contrast agent. Radiology, 1997, 203:281-285. 被引量：1
8Papanikolaou N, Karantanas A, Maris T, et al. MR cholangiopancreatography before and after oral blueberry juice administration. J Comput Assist Tomogr, 2000,24:229-234. 被引量：1
9Chan JH, Tsui EY, Yuen MK, et al. Gadopentetate dimeglumine as an oral negative gastrointestinal contrast agent for MRCP. Abdom Imaging, 2000,25:405-408. 被引量：1
